TY - CHAP A1 - Muhammad Shafique A2 - Muhammad Asif Zahoor A3 - Muhammad Imran Arshad A4 - Bilal Aslam A5 - Abu Baker Siddique A6 - Muhammad Hidayat Rasool A7 - Muhammad Usman Qamar A8 - Muhammad Usman ED1 - Bernhard Resch Y1 - 2019-10-30 PY - 2019 T1 - Hurdles in Vaccine Development against Respiratory Syncytial Virus N2 - Respiratory syncytial virus (RSV) causes seasonal epidemics during the winter and wet seasons, particularly in young children. Although there is one drug available for prophylaxis, palivizumab, it is indicated for high-risk children only. Therefore a vaccine is urgently needed. This book provides an overview of RSV and discusses its incidence and presentation in different populations, including preterm infants and children with congenital heart disease. It also discusses future strategies for RSV prophylaxis and developments in and barriers to creating a viable vaccine. BT - The Burden of Respiratory Syncytial Virus Infection in the Young SP - Ch. 5 UR - https://doi.org/10.5772/intechopen.87126 DO - 10.5772/intechopen.87126 SN - 978-1-78984-643-0 PB - IntechOpen CY - Rijeka Y2 - 2022-01-23 ER -